# OnCo record dendritic-cell-vaccines (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/dendritic-cell-vaccines/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "dendritic-cell-vaccines" ;
  schema:name "Dendritic cell vaccines"@en ;
  schema:alternateName "Dendritic cell vaccine"@en, "DC vaccine"@en ;
  schema:description "Vaccines made from a patient's own antigen-presenting cells loaded with tumour proteins; sipuleucel-T for prostate cancer was the first approved, and newer versions are tested in brain and other cancers."@en ;
  schema:url <https://onco.cc/technologies/dendritic-cell-vaccines/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Sipuleucel-T> ;
  schema:citation <https://en.wikipedia.org/wiki/Sipuleucel-T> ;
  onco:status "approved" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/glioblastoma/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:targets <https://onco.cc/targets/pap/> ;
  onco:drugs <https://onco.cc/drugs/sipuleucel-t/> ;
  onco:companies <https://onco.cc/companies/argos-therapeutics/>, <https://onco.cc/companies/medigene/> ;
  onco:institutions <https://onco.cc/institutions/immunocine/> ;
  onco:trials <https://onco.cc/trials/nct07146672/> ;
  onco:dependsOn <https://onco.cc/technologies/apheresis-starting-material/>, <https://onco.cc/technologies/cell-therapy-release-testing/> .